Genmab | GEN - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Almirall EUR 199.26M 7.76M 2026-06
Amarin USD 26.05M 1.41M 2025-12
Amgen USD 1.87B 271M 2026-06
argenx SE USD 145M 24M 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Bayer EUR 5.23B 731M 2026-03
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Demant DKK 2.89B 188M 2025-12
Exelixis USD 19.95M 6.53M 2026-03
Fresenius Medical Care EUR 3.43B 248M 2026-03
Genmab DKK 84M 19M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
GN Store Nord DKK 1.16B 1.08B 2026-03
GRIFOLS EUR 1.17B 90M 2026-06
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Insmed USD 69.29M 19.79M 2026-06
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.07B 219M 2026-03
Novartis USD 3.71B 251M 2026-06
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.02B 656M 2026-06
UCB EUR 1.07B 146M 2025-12